Jacques Dumas
Venture Partner
Works at AdBio partners (ex Advent France Biotechnology)
Investor profile | Builders Republic
About
Venture Partner at AdBio partners, Jacques Dumas invests in seed and Series A with check sizes of €1 to €3 million, focusing on health and life sciences, with a drug discovery angle. A consultant for AdBio since 2023, he joined the fund in 2025. He has spent over 30 years in drug discovery and development: currently the CSO of AiCuris, he was previously the CSO at Arrakis, Tetraphase, and Idenix.
Profile
- Role
- Venture Partner
- Fund
- AdBio partners (ex Advent France Biotechnology)